Musculoskeletal Disorders and Osteoporosis, Ucb: "Transforming Research Into Accessible Care"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
(Adnkronos) - Recognize the disease promptly, ensure homogeneous access to treatment,...
(Adnkronos) - Recognize the disease promptly, ensure consistent access to treatment, ensure appropriate care paths and accompany people over time. It is to these objectives that Ucb Pharma draws attention — on the occasion of World Osteoporosis Day, which is celebrated today, October 20, and the World Day of Rheumatic Patients, celebrated on October 12 [...]
notizie.it
Rec News | Lontani dal mainstream(Adnkronos) - Recognize the disease promptly, ensure homogeneous access to care, ensure appropriate care paths and accompany the
On the occasion of the World Day of the Sick and the World Day of the Osteoporosis, UCB Pharma draws attention to early diagnosis, therapeutic innovation and fairness in access to treatment. At the center also the role of patient associations, multidisciplinary care paths and the prevention of frailty fractures The post UCB Pharma, rheumatological diseases and osteoporosis: therapeutic innovation, patient listening and equity in accessing the ca…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
